CLINICAL RESEARCH: HEART FAILURE
Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic DysfunctionA Pooled Analysis of 5 Randomized Control Trials
Camille G. Frazier, MD*,
Karen P. Alexander, MD*,
L. Kristin Newby, MD, MHS*,
Susan Anderson, MS ,
Erik Iverson, MS,
Milton Packer, MD ,
Jay Cohn, MD ,
Sidney Goldstein, MD|| and
Pamela S. Douglas, MD*,*
* Division of Cardiovascular Medicine, Duke University Medical Center, Durham, North Carolina
Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin
University of Texas, Southwestern Medical Center, Dallas, Texas
University of Minnesota Medical Center, Minneapolis, Minnesota
|| Henry Ford Health System, Detroit, Michigan
Manuscript received June 15, 2006;
revised manuscript received November 17, 2006,
accepted November 17, 2006.
* Reprint requests and correspondence: Dr. Pamela S. Douglas, Duke University Medical Center, DUMC 3943, Duke North 7451, Durham, North Carolina 27710. (Email: pamela.douglas{at}duke.edu).
Objectives: This study sought to explore the gender-related differences in etiology and outcomes in chronic heart failure (HF) patients from 5 randomized trials.
Background: Each year, 550,000 new cases of HF are identified; however, there remain limited data on gender-related differences in etiology and outcomes among patients with HF with systolic dysfunction.
Methods: We analyzed data from 8,791 men and 2,851 women randomized in 5 clinical trials (PRAISE [Prospective Randomized Amlodipine Survival Evaluation], PRAISE-2, MERIT-HF [Metoprolol Extended Release Randomized Intervention Trial in Heart Failure], VEST [Vesnarinone Trial], and PROMISE [Prospective Randomized Milrinone Survival Evaluation]) to explore gender-related differences in etiology (ischemic vs. nonischemic) and outcomes (all-cause mortality and death or all-cause hospitalization). Hazard ratios (HR), 95% confidence intervals (CIs), and Kaplan-Meier survival curves were generated by gender and etiology.
Results: A total of 18% of ischemic and 31% of nonischemic patients were women. Irrespective of etiology, women were older, more ethnically diverse, and had higher systolic blood pressures, more diabetes, and severe HF symptoms, but less often smoked or had prior myocardial infarctions than men. Mean ejection fractions were similar between women (23.6%) and men (23.2%). The 1-year Kaplan-Meier survival estimates varied by gender and etiology (female nonischemics, HR 0.88 [95% CI 0.85 to 0.89]; female ischemics, HR 0.83 [95% CI 0.81 to 0.85]; male nonischemics, HR 0.84 [95% CI 0.83 to 0.85]; male ischemics, HR 0.79 [95% CI 0.78 to 0.81]). After adjustment, female gender (HR 0.77 [95% CI 0.69 to 0.85]) and nonischemic etiology (HR 0.80 [95% CI 0.72 to 0.89]) were associated with longer survival time. Time to death or hospitalization was longer among nonischemics (HR 0.83 [95% CI 0.78 to 0.89], p < 0.0001); however, female gender was not significantly associated with the composite outcome (HR 1.01 [95% CI 0.95 to 1.08]).
Conclusions: Our data clarify that outcomes differ by both gender and etiology among patients with HF with systolic dysfunction. Understanding these differences may lead to better management of HF patients and improved overall prognosis.
|
Abbreviations and Acronyms
| | CI = confidence interval | | HF = heart failure | | HR = hazard ratio | | LVEF = left ventricular ejection fraction | | MI = myocardial infarction | | NYHA = New York Heart Association |
|
This article has been cited by other articles:
|
|
|
|
 
D. H. Kwon, C. M. Halley, Z. B. Popovic, T. P. Carrigan, V. Zysek, R. Setser, P. Schoenhagen, S. D. Flamm, R. C. Starling, and M. Y. Desai
Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance
Eur J Heart Fail,
October 1, 2009;
11(10):
937 - 944.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ghanbari, G. Dalloul, R. Hasan, M. Daccarett, S. Saba, S. David, and C. Machado
Effectiveness of Implantable Cardioverter-Defibrillators for the Primary Prevention of Sudden Cardiac Death in Women With Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials
Arch Intern Med,
September 14, 2009;
169(16):
1500 - 1506.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Lee, P. Gona, R. S. Vasan, M. G. Larson, E. J. Benjamin, T. J. Wang, J. V. Tu, and D. Levy
Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute
Circulation,
June 23, 2009;
119(24):
3070 - 3077.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Okura, Y. Takada, A. Yamabe, T. Kubo, K. Asawa, T. Ozaki, H. Yamagishi, I. Toda, M. Yoshiyama, J. Yoshikawa, et al.
Age- and Gender-Specific Changes in the Left Ventricular Relaxation: A Doppler Echocardiographic Study in Healthy Individuals
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
41 - 46.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A. Poole-Wilson
Global Differences in the Outcome of Heart Failure: Implications for Clinical Practice
J. Am. Coll. Cardiol.,
November 11, 2008;
52(20):
1649 - 1651.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. M. Albert and C. Lewis
Recognizing and Managing Asymptomatic Left Ventricular Dysfunction: After Myocardial Infarction
Crit. Care Nurse,
April 1, 2008;
28(2):
20 - 37.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Fauchier, B. Pierre, A. de Labriolle, and D. Babuty
Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: A meta-analysis of randomised controlled trials
Eur J Heart Fail,
November 1, 2007;
9(11):
1136 - 1139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
